SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzymes to acquire 70% stake in JC Biotech

28 Oct 2016 Evaluate

Advanced Enzyme Technologies has entered into definitive agreements with API maker JC Biotech to acquire 70% stake for a consideration of Rs 50 crore. The proposed transaction was approved by the board of Advanced Enzymes on October 28, 2016. The acquisition is expected to close latest by end of December 2016. Advanced Enzymes will finance the acquisition largely through internal accruals. Upon closing, the acquisition is expected to be accretive to Advanced Enzymes' EPS for FY17.

Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.

Advanced Enzyme Share Price

299.35 0.35 (0.12%)
21-Apr-2026 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.35
Dr. Reddys Lab 1220.00
Cipla 1232.60
Zydus Lifesciences 928.40
Lupin 2322.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×